Natural products: a hope for glioblastoma patients

Glioblastoma (GBM) is one of the most aggressive malignant tumors with an overall dismal survival averaging one year despite multimodality therapeutic interventions including surgery, radiotherapy and concomitant and adjuvant chemotherapy. Few drugs are FDA approved for GBM, and the addition of temo...

Descripción completa

Detalles Bibliográficos
Autores principales: Vengoji, Raghupathy, Macha, Muzafar A., Batra, Surinder K., Shonka, Nicole A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955138/
https://www.ncbi.nlm.nih.gov/pubmed/29774132
http://dx.doi.org/10.18632/oncotarget.25175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5955138/
https://www.ncbi.nlm.nih.gov/pubmed/29774132
http://dx.doi.org/10.18632/oncotarget.25175

Ejemplares similares